Annovis Bio, Inc. (ANVS)
NYSE: ANVS · Real-Time Price · USD
1.720
+0.070 (4.24%)
At close: Jun 26, 2026, 4:00 PM EDT
1.745
+0.024 (1.42%)
After-hours: Jun 26, 2026, 7:39 PM EDT
Annovis Bio Employees
Annovis Bio had 7 employees as of December 31, 2025. The number of employees decreased by 8 or -53.33% compared to the previous year.
Employees
7
Change (1Y)
-8
Growth (1Y)
-53.33%
Revenue / Employee
n/a
Profits / Employee
-$5,846,216
Market Cap
73.17M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 7 | -8 | -53.33% | 7 | 0 |
| Dec 31, 2024 | 15 | -1 | -6.25% | 8 | 7 |
| Dec 31, 2023 | 16 | 11 | 220.00% | 6 | 10 |
| Dec 31, 2022 | 5 | 2 | 66.67% | 5 | 0 |
| Dec 31, 2021 | 3 | 1 | 50.00% | 3 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Gossamer Bio | 162 |
| MindWalk Holdings | 102 |
| XBiotech | 87 |
| Acrivon Therapeutics | 76 |
| Seres Therapeutics | 66 |
| Pliant Therapeutics | 49 |
| BeyondSpring | 44 |
| Elicio Therapeutics | 33 |
ANVS News
- 4 weeks ago - Annovis Bio regains NYSE listing compliance - TheFly
- 4 weeks ago - Annovis Bio Regains NYSE Listing Compliance - GlobeNewsWire
- 5 weeks ago - Annovis Bio 7.9M share Spot Secondary priced at $1.90 - TheFly
- 5 weeks ago - Annovis Announces Pricing of $15.0 Million Public Offering of Common Stock and Accompanying Warrants - GlobeNewsWire
- 5 weeks ago - Annovis Bio announces common stock and warrants offering, no amount given - TheFly
- 5 weeks ago - Annovis Announces Launch of Proposed Public Offering of Common Stock and Accompanying Warrants - GlobeNewsWire
- 6 weeks ago - Annovis Provides Corporate Updates and Reports First Quarter 2026 Financial Results - GlobeNewsWire
- 6 weeks ago - Annovis Bio Quarterly report: Q1 2026 - Filings